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Abstract  
At intestinal level, after acute or chronic exposure to iNOS-derived NO a toxic mechanism of action 
leads to inflammation and degenerative diseases. The aim of this study was to investigate the effect 
of glucuronide and sulfate metabolites of the extra virgin olive oil phenols tyrosol (Tyr) and 
hydroxytyrosol (HT), in comparison with their parent compounds, on the release of NO following 
exposure to a pro-inflammatory stimulus, the bacterial lipopolysaccharide (LPS). Human colon 
adenocarcinoma cells (Caco-2), differentiated as normal enterocytes, were treated with pathological 
concentrations of LPS, in order to stimulate iNOS pathway, which involve NF-ĸB activation 
through IĸBα phosphorylation and subsequent degradation induced by Akt or MAPKs. All the 
tested metabolites inhibited NO release induced by LPS, acting as inhibitors of iNOS expression, 
with an efficacy comparable to that of the parent compounds. HT and Tyr metabolites were 
effective in the inhibition of IĸBα degradation. No one of the compounds was able to inhibit Akt 
activation, whereas they modulated p38 and ERK1/2 MAPK. Obtained data show that HT and Tyr 
metabolites are able to prevent a pathological NO overproduction at intestinal level, where they 
concentrate, thus significantly contributing to the protective activity exerted by their parent 
compounds against inflammation. 
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1. Introduction  
Nitric oxide (NO) is a free radical compound which plays an important cellular signaling role 
within the mammalian body, where it is involved in many physiological and pathological processes 
(Habib and Ali, 2011; He et al., 2014). In the intestinal epithelium, NO production is strictly linked 
to the activation of the inducible nitric oxide synthase (iNOS) (Serra et al., 2018). At this level, NO 
may play, at low concentrations, a protective role against the inflammatory process, while after 
acute or chronic exposure a toxic mechanism of action leads to injurious effects. Indeed, its chronic 
release at high concentrations, due to an up-regulation of iNOS, have been correlated with the 
pathogenesis of inflammatory bowel diseases (IBD) (Marion et al., 2003) and colon cancer (Rao, 
2004), mainly through the generation of peroxynitrite (Soufli et al., 2016). Several dietary 
phytochemicals have already been studied for their ability to act as anti-inflammatory agents, 
limiting NO abnormal release in intestinal cells through the inhibition of iNOS expression (Panaro 
et al., 2012; Romier-Crouzet et al., 2009; Somchit et al., 2014). The nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) is a central target for the induction of iNOS expression 
by pro-inflammatory agents such as lipopolysaccharide (LPS) and stimulatory cytokines like 
interferon-γ (IFN-γ), interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-
α) (Abbas et al., 2016; Kleinert et al., 2003). This nuclear factor is usually activated after 
phosphorylation and subsequent degradation of its inhibitor IκB, which is present in three different 
isoforms, IκBα, IκBβ, and IκBɛ (Kanarek et al., 2010). The extent of IκB degradation depends on 
the activation of the IκB kinase (IKK) enzyme complex, which could be activated through the 
PI3/Akt (serine/threonine protein kinase) pathway (Kane et al., 1999). Akt can also regulate 
signaling pathways that lead to the induction of the NF-ĸB family of transcription factors, and it is 
specific for NF-ĸB, as other inducible transcription factors such as the Nuclear factor of activated T 
cells (NFAT) and the Activator protein 1 (AP-1) are not affected by Akt overexpression (Kane et 
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al., 1999). IĸB phosphorylation could also be led by activating key protein kinases such as mitogen 
activated protein kinases (MAPKs) p38, JNK, and ERK1/2 (Serra et al., 2018). 
Phenolic compounds present in extra virgin olive oil, have been demonstrated to exert many 
potentially beneficial biological effects, starting at intestinal level (Deiana et al., 2018); in this site 
some of them, namely hydroxytyrosol (HT) and tyrosol (Tyr), may reach quite high concentrations, 
in the high μM range (Scalbert and Williamson, 2000). 
Indeed, the bioavailability of HT and Tyr is poor due to an extensive metabolism (Rodriguez-
Morato et al., 2016). Miro-Casas et al. (2003) showed that sulfated and glucuronidated HT and Tyr 
were the predominant metabolites found in human plasma and urine, and they have also been shown 
to concentrate in the intestinal lumen. Indeed, the content of sulfate and glucuronide metabolites in 
intestinal cells is relevant, due to intensive glucuronidation and sulfation which are major pathways 
of phase II xenobiotic metabolism in the human intestine (Rubiò et al., 2014a). Thus, at this location 
major metabolites might significantly contribute to the protective action ascribed to their parent 
compounds, acting as antioxidants and anti-inflammatory agents (Serreli et al., 2018). Nevertheless, 
recent studies pointed out that sulfate and glucuronide moieties can be deconjugated once they get 
intracellular environment, thus they may act also as free parent compounds (Catalan et al., 2015; 
Rubiò et al., 2014b). 
HT and Tyr have been widely studied for their numerous beneficial effects against cardiovascular 
(Bulotta et al., 2014; Hu et al., 2014; Muriana et al., 2017), neuronal (Hu et al., 2014), intestinal 
(Deiana et al., 2018) and neoplastic diseases (Casaburi et al., 2013). These compounds are well 
known for their direct antioxidant capacity (Bulotta et al., 2014; Rodriguez-Morato et al., 2016) but 
they are also able to modulate molecular pathways acting as indirect antioxidant, anti-inflammatory 
(Cicerale et al., 2012; Santangelo et al., 2018), anti-proliferative (Corona et al., 2009) and anticancer 
agents (Guichard et al., 2006).  
In previous studies, HT proved to be effective in the downregulation of kinases such as MAPKs, 
ERK1/2 and JNK, and Akt, counteracting H2O2-induced injury in enterocytes and inhibiting the 
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proliferation of human colon adenocarcinoma cells (Corona et al., 2009). HT and Tyr have also 
been found to reduce pro-inflammatory cytokines secretion in peripheral blood mononuclear cells 
by modulating p38 and JNK kinases (Serra et al., 2017). The activation of these kinases in response 
to pro-inflammatory stimuli (namely TNF-α, IFN-γ, IL-6, and IL-1α), and bacterial component LPS 
is known to be involved in the expression of iNOS, responsible for the increased NO production at 
the site of inflammation (Murakami, 2009; Viatour et al., 2005).  
The goal of this study was to evaluate the ability of HT and Tyr sulfate and glucuronide 
metabolites, in comparison with their parent compounds, to act as anti-inflammatory agents through 
the inhibition of NO over-release in human colon adenocarcinoma cells (Caco-2) differentiated as 
normal enterocytes, following treatment with pathological concentrations of LPS. In particular, we 
focused our attention on the mechanisms of their modulatory action on iNOS expression, 
investigating their ability to modulate Akt signaling pathway or MAPKs (JNK, p38 and ERK1/2) in 
relation to NF-κB activation.   
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2. Materials and methods  
2.1 Chemicals 
LPS from Escherichia coli, Tyr (2-(4-Hydroxyphenyl)ethanol, purity 98%, cod. 188255, CAS 
Number 501-94-0), HT (2-(3,4-Dihydroxyphenyl)ethanol, purity 98%, cod. H4291, CAS Number: 
10597-60-1), L-arginine, sodium nitrite, Griess’ reagent, Bradford reagent, Phosphatase Inhibitor 
Cocktail II, Protease Inhibitor Cocktail and Thiazolyl Blue Tetrazolium Bromide (MTT) were 
purchased from Sigma Aldrich (Milan, Italy). Tyr sulf (p-Hydroxyphenethyl Alcohol p-(Hydrogen 
Sulfate) Sodium Salt; 4-(Sulfooxy)benzeneethanol Sodium Salt, purity 98%, cod. T947815, CAS 
Number: not available), HT sulf (4-(2-Hydroxyethyl)-1,2-benzenediol 2-(Hydrogen Sulfate) 
Sodium, purity 98%, cod. H977010, CAS Number: 1391053-88-5), HT glu (2-Hydroxy-5-(2-
hydroxyethyl)phenyl β-D-Glucopyranosiduronic Acid, purity 97%, cod. H977000, CAS Number: 
425408-50-0), and Tyr glu (4-(2-Hydroxyethyl)phenyl β-D-Glucopyranosiduronic Acid, purity 
98%, cod. T947810, CAS number: 28116-28-1) were purchased from Toronto Research Chemicals 
(North York, ON, Canada). Cell culture materials were purchased from Invitrogen (Milan, Italy). 
Phenolic compounds were dissolved in MeOH (stock solution 1 mg/mL) and stored at -20°C. LPS 
was freshly prepared as a water solution (1 mg/mL) just before treatments. 
 
2.2. Cell cultures 
Caco-2 cells (ECACC Salisbury, Wiltshire UK) were cultured in Dulbecco's modified Eagle's 
medium (DMEM), supplemented with 10% heat-inactivated bovine serum, 2 mM L-glutamine, 1% 
non-essential amino acids, 100 U/ml penicillin, and 100 mg/ml streptomycin, in monolayers at 
37°C in a humidified atmosphere of 5% CO2 (Incani et al., 2016), replacing the medium twice a 
week. For experimental studies Caco-2 cells, at passage 45-60, were plated and used 18-21 days 
post seeding, when fully differentiated.  
 
2.3. MTT viability test 
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The MTT assay was assessed on Caco-2 cells (Rosa et al., 2011) in order to evaluate any toxic 
activity of the tested compounds. Cells were seeded in 96-well plates (5x104 viable cells /mL in 100 
μL), exposed to various concentrations of the compounds alone (HT, Tyr, Tyr sulfate, HT sulfate, 
HT glucuronide and Tyr glucuronide at 0.1, 1 and 10 μM, in serum free medium) or to the same 
phenolic compounds preincubated (1 μM, 30 min) prior to LPS co-exposure (LPS 1 µg/mL ) or an 
equivalent volume of MeOH (vehicle of all the compounds) for the controls, and incubated for 72 h. 
After incubation, the medium was removed and 100 μL of MTT solution (5 mg/mL of fresh 
medium) was added and left for 6 h at 37°C. The medium was then aspirated, 100 μL of dimethyl 
sulfoxide (DMSO) were added in each well and the absorbance was read at 570 nm by using a 
micro plate reader (Infinite 200, Tecan, Salzburg, Austria).  
 
2.4. Measure of nitric oxide  
In order to evaluate NO production, Caco-2 cells were cultured in 6-well plates (5x104 cells/mL in 2 
mL) in phenol red-free DMEM with L-arginine 0.1 mM and 2.5% fetal bovine serum. A time 
course analysis of NO release was performed by incubating cells from 0 to 72 h after treatments 
with LPS 1 µg/mL. In another set of experiments, cells were pretreated with the phenolic 
compounds tested in this study (HT, Tyr, Tyr sulfate, HT sulfate, HT glucuronide and Tyr 
glucuronide at 1 μM for 30 min) prior to LPS co-exposure (1 µg/mL) for 48 h. After incubation, the 
medium was collected from the wells and the nitrite concentration was determined by mixing 100 
μL of the same medium with an equal volume of Griess’ reagent and incubating for 20 min at room 
temperature. Then, plate was read at 540 nm, and nitrite levels were determined with a sodium 
nitrite standard curve ranging from 0.1 to 10 μM. The results were expressed as μM of nitrites 
secreted by the cells. 
 
2.5. Western blot analyses 
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To assess western blot analyses, Caco-2 cells were seeded in 6-well plates (5x104 cells/mL in 2 mL) 
in DMEM with L-arginine 0.1 mM and 2.5% fetal bovine serum. Once differentiated, cells were 
pretreated with the phenolic compounds (HT, Tyr, Tyr sulfate, HT sulfate, HT glucuronide and Tyr 
glucuronide at 1 μM for 30 min) prior to LPS co-exposure (1 µg/mL) for 2 or 48 h. Then, 
supernatant was removed and Caco-2 cells were lysed in 200 µL of commercial lysis buffer 
CellLytic M (Sigma Aldrich, Milan, Italy) supplemented with PierceTM phosphatase and protease 
inhibitor mini tablets (Thermo Fisher Scientific, Waltham, MA, USA) for protein extraction. 
Lysates were centrifuged (15.000 x g, 10 min, 4°C), supernatants collected and used to determine 
total protein concentration by the Bradford assay (Bradford, 1976) or stored at -20°C to be used for 
western blot assays. Twenty micrograms of reduced and denatured proteins were separated on 10% 
polyacrylamide gels and thereupon transferred into nitrocellulose membranes. Membranes were 
blocked with 25 mL of TTBS (tris-buffered saline with Tween 20, composed by Tris/HCl 20 mM, 
pH 7.5, 100 mM NaCl and 0.1% Tween 20) 4% dry milk for 30 min at room temperature. Primary 
poly-clonal antibodies, anti-IĸBα, anti-phospho IĸBα, anti-Akt, anti-phospho Akt, anti-β actin, anti-
ERK1/2, anti-phospho ERK1/2, anti-p38, anti-phospho p38, anti-JNK, anti-phospho JNK and anti-
iNOS antibodies, (Cell Signaling Technology, Inc., Danvers, Massachussets, USA) in TTBS 1% 
dry milk (dilution 1:1000) were added to the membranes and kept overnight on a three-dimensional 
rocking table at 4°C. Membranes were washed two times with TTBS before incubation with goat 
secondary anti-rabbit IgG conjugated to horseradish peroxidase (1:2000 dilution) (Sigma Aldrich, 
Milan, Italy) in TTBS  1% milk for 45 min at room temperature and then washed twice with TTBS 
and once with TBS (Tris/HCl 20 mM, pH 7.5 and 100 mM NaCl). The bands were visualized by 
using the ChemiDoc™ XRS+ System (Bio-Rad Laboratories, Inc., Hercules, California, USA). 
 
2.5. Statistical Analyses 
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One-way analysis of variance (ANOVA) followed by Tukey’s test was performed in order to 
highlight possible significant differences between groups (p < 0.05) using the GraphPad Prism 5 
software (GraphPad software, San Diego, CA, USA).   
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3.  Results 
3.1. Evaluation of cell viability 
To investigate the potential protective effect of HT and Tyr sulfate and glucuronide metabolites, in 
comparison with their parent compounds, against LPS-induced pro-inflammatory effects in Caco-2 
cell monolayers, control experiments were initially carried out to assess cell viability after treatment 
with the phenolic compounds, LPS alone or LPS in presence of the compounds. As reported in 
Figure 1, cell viability remained unchanged in presence of the tested phenolic compounds in the 
concentration range 0.1–10 µM and in presence of the chosen concentration of LPS (1 µg/mL) 
alone or co-incubated with the phenolic compounds (1 μM, pre-incubated 30 min prior to LPS co-
exposure). 
 
Fig.1. Percentage of cell viability compared to control (100%) of Caco-2 cells incubated for 72 h with different 
concentrations of hydroxytyrosol (HT), tyrosol (Tyr) and their glucuronide (glu) and sulfate (sulf) metabolites (0.1-10 
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μM) (A) or incubated with LPS (1 µg/mL) alone or co-incubated with the phenolic compounds (1 μM, pre-incubated 30 
min prior to LPS co-exposure) (B). Each column represents the mean ± SD of independent experiments (n=12).  
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3.2. Effect on NO production and iNOS expression 
NO release in Caco-2 cells after treatment with LPS for 0-72 h was measured as nitrites content in 
culture medium. LPS was able to induce NO release, showing significant differences in nitrite levels 
compared to control starting from 48 h of incubation, where NO amount doubled for LPS treated 
samples (Figure 2). 
 
 
 
 
 
 
 
 
Fig.2. NO production (expressed as µM of nitrites) in Caco-2 cells untreated or treated with LPS (1 µg/mL) for 0-72 h. 
Measurements were assessed in supernatant by using Griess’ reagent method. Each column represents the mean ± SD of 
independent experiments (n=16). *= p < 0.05 LPS vs untreated cells at the same incubation time.  
 
NO production in Caco-2 cells after 48 h LPS exposure with and without pretreatment (30 min prior 
to LPS co-exposure) with the phenolic compounds (1 µM) was then analyzed. As shown in Figure 
3, all the compounds significantly counteracted NO production. Among the tested compounds, HT 
and HT sulfate were the most effective in limiting the release of NO, which level was 54% and 57% 
respectively of the amount detected in LPS treated cells, near to that of control.  
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Fig.3. NO production (expressed as µM of nitrites) in Caco-2 cells treated with LPS (1 µg/mL) for 48 h and pretreated 
(30 min) with hydroxytyrosol (HT), tyrosol (Tyr) and their glucuronide (glu) and sulfate (sulf) metabolites (1 µM) prior 
to LPS co-exposure. Measurements were assessed in supernatant by using Griess’ reagent method. Each column 
represents the mean ± SD of independent experiments (n=16). Significant differences among groups are reported using 
different superscript symbols (p < 0.05); * = significant vs control; # = significant vs LPS; ° = significant vs HT + LPS 
and HT sulf + LPS. 
 
A significant increase of iNOS expression in LPS treated cells with respect to the control was also 
observed in parallel to NO release. In Caco-2 cells pretreated with the phenolic compounds LPS 
induction of iNOS expression was significantly inhibited, though enzyme level was still higher than 
that of the control (Figure 4). All the metabolites exerted a significant effect (p < 0.05) in limiting 
iNOS expression with respect to the LPS treated samples, comparable to that of the parent 
compounds. 
 
 
 
 
 
14 
 
 
 
 
 
 
 
 
 
Fig.4. Expression of iNOS, reported as percentage of the control, in Caco-2 cells treated with LPS (1 μg/mL) for 48 h 
and pretreated (30 min) with hydroxytyrosol (HT), tyrosol (Tyr) and their glucuronide (glu) and sulfate (sulf) 
metabolites (1 μM) prior to LPS co-exposure. Each column represents the mean ± SD of independent experiments 
(n=6). Significant differences among groups are reported using different superscript symbols (p < 0.05); * = significant 
vs control; # = significant vs LPS; ° = significant vs HT sulf + LPS; § = significant vs Tyr sulf + LPS. Representative 
WB image of the treatment is shown. β-actin detection was used as a loading control for each sample. 
 
3.3. Prevention of IĸBα degradation  
IĸBα phosphorylation by IKK is a main step which allows NF-ĸB to modulate iNOS expression. 
Figure 5 reports the results of IĸBα modulation occurred in Caco-2 cells after LPS treatment for 48 
h. A western blot analysis was assessed to evaluate the ratio between IĸBα and its phosphorylated 
form. IĸBα phosphorylation was predominant in cells treated only with LPS, where phospho 
IĸBα/total IĸBα ratio was four times greater than that of the control, while pretreatment with HT 
and its sulfate and glucuronide metabolites and to a lesser extent with Tyr and metabolites 
significantly inhibited IĸBα phosphorylation, thus blocking its degradation.   
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Fig.5. Degradation of IĸBα reported as phospho IĸBα/total IĸBα ratio in Caco-2 cells treated with LPS (1 μg/mL) for 48 
h and pretreated (30 min) with hydroxytyrosol (HT), tyrosol (Tyr) and their glucuronide (glu) and sulfate (sulf) 
metabolites (1 μM) prior to LPS co-exposure. Each column represents the mean ± SD of independent experiments 
(n=6). Significant differences among groups are reported using different superscript symbols (p < 0.05); * = significant 
vs control; # = significant vs LPS; ° = significant vs HT glu + LPS and HT sulf + LPS. Representative WB image of the 
treatment is shown. 
 
3.4. Modulation of Akt and MAPK p38, JNK and ERK1/2 
The ability of the phenolic compounds to modulate LPS stimulation of intracellular signaling 
pathways involved in NO release was evaluated, focusing in particular on the Akt pathway and on 
MAPK JNK, p38 and ERK 1/2. As shown in Figure 6 and 7, incubation with LPS led to a 
significant change in Akt kinase, p38 and ERK1/2 phosphorylation state already after 2 h, as 
assessed by western blot analysis. The extent of Akt and ERK phosphorylation in cells treated only 
with LPS was three times, and twice in the case of p38, the one detected in the control, whereas 
JNK phosphorylation was not observed. None of the tested metabolites nor their parent compounds 
was able to modulate Akt phosphorylation, as phospho Akt/total Akt ratio was the same in all LPS 
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treated samples, irrespective to the presence of the phenolic compounds (Figure 6); all of them 
instead limited LPS effect on p38 and ERK1/2 activation. 
 
Fig.6. Activation of Akt reported as phospho Akt/total Akt ratio in Caco-2 cells treated with LPS (1 μg/mL) for 2 h and 
pretreated (30 min) with hydroxytyrosol (HT), tyrosol (Tyr) and their glucuronide (glu) and sulfate (sulf) metabolites (1 
μM) prior to LPS co-exposure. Each column represents the mean ± SD of independent experiments (n=6). Significant 
differences among groups are reported using different superscript symbols (p < 0.05); * = significant vs control. 
Representative WB image of the treatment is shown. 
 
Pretreatment with both HT and Tyr metabolites and their parent compounds exerted a comparable 
efficacy. p38 and ERK1/2 phosphorylation was significantly inhibited with respect to the cells 
treated with only LPS (p < 0.05), although the extent of the phosphorylation was still significantly 
above the control level (Figure 7).  
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Fig.7. Modulation of MAPK p38 (A) and ERK1/2 (B) reported as phospho p38/total p38 and phospho ERK1/2/total 
ERK1/2 ratios in Caco-2 cells treated with LPS (1 μg/mL) for 2 h and pretreated (30 min) with hydroxytyrosol (HT), 
tyrosol (Tyr) and their glucuronide (glu) and sulfate (sulf) metabolites (1 μM) ) prior to LPS co-exposure. Each column 
represents the mean ± SD of independent experiments (n=6). Significant differences among groups are reported using 
different superscript symbols (p < 0.05); (A) * = significant vs control; # = significant vs LPS; ° = significant vs HT glu 
+ LPS; (B) * = significant vs control; # = significant vs LPS; ° = significant vs HT + LPS. Representative WB image of 
the treatment is shown. 
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4.  Discussion  
Olive oil polyphenols are some of the most studied phenols for their health properties (Bendini et 
al., 2007; De la Torre, 2008). Among them, HT and Tyr are highly concentrated right at intestinal 
level (Scalbert & Williamson, 2000) and have been recognized to exert several health effects, acting 
not only as direct antioxidants but also influencing gene expression and intracellular signaling 
mechanisms (Serreli et al., 2018). However, the relevance of in vitro data for the interpretation of in 
vivo effects of these phenols is controversial, since the oral bioavailability of these compounds is 
rather limited due to their metabolization mainly to sulfates and glucuronides (Serreli et al., 2018).  
The present study aimed to explore for the first time the ability of HT and Tyr glucuronide and 
sulfate metabolites, in comparison to their parent compounds, to act as anti-inflammatory agents by 
the modulation of iNOS-derived NO production at intestinal level. Compounds were tested at a 
biologically relevant concentration, 1 μM, which could be found in circulation after dietary 
consumption (Pastor et al., 2016) as well as in the gut lumen, where they may reach even higher 
concentrations (Jenner et al., 2005). 
As a model of human intestinal epithelium Caco-2 cell monolayers were used. These cells derive 
from a human colon adenocarcinoma; once in culture they undergo a process of spontaneous 
differentiation into normal mature enterocytes (Jochems et al., 2018). iNOS is not usually expressed 
in these cells, but its expression can be induced by bacterial LPS, cytokines, and other toxic or pro-
inflammatory agents (Förstermann & Sessa, 2012). Once expressed, iNOS is constantly active and 
not regulated by intracellular Ca2+ concentrations and produces large amounts of NO (Förstermann 
& Sessa, 2012). In order to activate the pathway which leads to NO production, Caco-2 cells were 
treated with the pro-inflammatory agent LPS, given at the pathological concentration of 1 μg/mL 
(Guo et al., 2015), which has already been used for this purpose in other studies (Panaro et al., 2012; 
Romier et al., 2008; Van de Walle et al., 2010). LPS, the major cell wall component of Gram-
negative bacteria, is abundant in the gut lumen and it is correlated to the pathogenesis of IBD when 
it reaches elevated circulating levels (over 10 ng/mL) (Guo et al., 2013). In Caco-2 cells LPS 
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exposure led to a highly significant production of NO, whose level was doubled with respect to the 
control, as a consequence of iNOS activation. NO overproduction was prevented by all the tested 
compounds, that reduced the level detected in LPS treated cells, up to 50% in the case of HT and 
HT sulfate. This partial inhibition of NO production is biologically relevant, as the maintenance of 
intestinal homeostasis is associated with the release of low concentrations of NO, which can play a 
protective role (Chokshi et al., 2008). Conversely, an excessive and prolonged iNOS-derived NO 
can lead to inflammatory conditions that increase mucosal permeability, thus triggering IBD (Chen 
and Kitts, 2015). 
The protective action of the tested phenolic compounds was due to their ability to inhibit iNOS 
expression in Caco-2 cells, as indicated by western blot analysis. iNOS down-regulation by HT, HT 
acetate and some other HT derivatives was demonstrated by Maiuri et al. (2005) and Aparicio-Soto 
et al. (2015) in two different macrophage cell lines. Other studies highlighted the capacity of 
polyphenols with different chemical structures to inhibit iNOS expression in Caco-2 cells: 
resveratrol, for instance, acted as iNOS inhibitor (Cosan et al., 2010), counteracting NF-κB 
activation through IĸBα degradation (Panaro et al., 2012). iNOS is usually over-expressed after 
activation of NF-kB (Serra et al., 2018), which is consequent to its translocation into the nucleus. 
This translocation is allowed when its inhibitor IĸBα gets phosphorylated by its kinase IKK (Gupta 
et al., 2010) which, in turn, could be activated by phosphorylated Akt or other kinases (Hoesel and 
Schmidt, 2013). It was previously shown that polyphenols can modulate this pathway, influencing 
NF-ĸB-induced iNOS gene expression (Bognar et al., 2013; Panaro et al., 2012). Hence, we 
evaluated the ability of HT and Tyr metabolites and their parent compounds to inhibit iNOS 
expression through NF-ĸB modulation, acting on IĸBα. LPS treatment induced an increase of the 
phospho IĸBα/total IĸBα ratio, which was reverted in presence of the phenolic compounds. It is 
interesting to note that compounds which better inhibited NO production, HT and HT sulfate, were 
also the most effective, together with HT glucuronide, in blocking IĸBα phosphorylation and then 
NF-ĸB activation. A possible mechanism of the outstanding activity of these compounds in 
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counteracting IĸBα degradation could be linked to the ability to inhibit LPS-induced Akt 
phosphorylation. Indeed, Caco-2 cells treated with LPS showed a significant increase in Akt 
phosphorylation, in accordance to Xiong et al. (2015). However, pretreatment with the tested 
phenolic compounds did not exert in our experimental conditions any effect on Akt 
phosphorylation, contrary to what demonstrated in hepatocellular carcinoma (Zhao et al., 2014), and 
neuronal cells (Fu and Hu, 2016) treated with HT. Beyond the Akt-induced IKK activation, LPS is 
known to induce IĸB phosphorylation also through the activation of kinases such as MAPK p38, 
JNK, and ERK1/2, all of which are involved in activating key transcription factors, including NF-
ĸB (Murakami et al., 2009). In support of the MAPKs down-regulation in the context of IĸBα 
phosphorylation, Cardeno et al. (2014) proved in murine macrophages that olive oil phenolic 
extracts reduced LPS-induced oxidative stress and inflammatory responses, through the down-
regulation of iNOS, which was linked to a reduced MAPKs phosphorylation and nuclear NF-κB 
translocation. In this study, LPS treatment in Caco-2 cells induced phosphorylation of MAPK p38 
and ERK1/2, while no significant change in the phospho/total ratio of JNK was observed. It is 
conceivable that the concentration of LPS used (1 µg/mL) was not adequate to stimulate JNK 
activation. In fact, JNK activation in Caco-2 cells, as well as p38 and ERK1/2, was observed by Sun 
et al. (2013) with concentration of LPS 10-fold higher. Overall, all the compounds tested in this 
study were effective in counteracting p38 and ERK1/2 LPS-induced activation. This finding is in 
agreement with other studies regarding olive oil phenolics and their capacity of down-regulating 
MAPKs activity in intestinal (Serra et al., 2018) endothelial (Catalan et al., 2018), peripheral blood 
(Serra et al., 2017), and kidney cells (Aparicio-Soto et al., 2016; Incani et al., 2010; Deiana et al., 
2011). It is noteworthy that the major metabolites of HT and Tyr, glucuronides and sulfates, which 
are usually found at higher concentrations than the parent compounds at systemic and intestinal 
level after olive products ingestion, showed in our experimental system to essentially retain parental 
biological activity, in accordance with previous data demonstrating the effectiveness of some 
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glucuronide and sulfate metabolites in the regulation of many cell signals (Atzeri et al., 2016; 
Heleno et al., 2015).  
Thus, it seems that glucuronide and sulfate chemical groups do not modify the properties of the 
parent compounds. This could be attributable to an eventual loss of the sulfate/glucuronide moiety 
once the metabolites enter Caco-2 cells so forming HT and Tyr, as previously demonstrated in the 
same experimental conditions (Atzeri et al., 2016). However, HT and Tyr themselves, once inside 
the cell, could be metabolized into sulfate and glucuronide forms, and act as metabolites, 
modulating cellular signaling pathways activated in response to oxidative stress and pro-
inflammatory stimuli (Atzeri et al., 2016).  
 
4.1 Conclusions 
This study highlighted for the first time the ability of HT and Tyr sulfate and glucuronide 
metabolites to inhibit iNOS-derived NO overproduction in intestinal Caco-2 cells. It should be 
emphasized that, as NO is one of the key mediators of the inflammatory process, this inhibitory 
action, that is likely to occur in the human intestinal lumen, may be particularly relevant in the 
maintenance of intestinal homeostasis. This effect was achieved through the modulation of IĸBα 
degradation, due to inhibitory effects on MAPKs but not on Akt. Sulfates and glucuronides, major 
metabolites of HT and Tyr, showed an efficiency comparable to that of the parent compounds, 
strengthening the assumption that the potential beneficial effect of the ingested parent compounds 
may be retained, even when extensive metabolisation occurs.  
The pool of compounds that concentrate at intestinal level following olive products ingestion, 
simple phenols and metabolites, all of which are probably in part responsible for the final effect, 
may significantly contribute to preserve intestinal integrity against pro-inflammatory agents, thus 
preventing or limiting the onset and progression of chronic intestinal inflammation and related 
diseases. 
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